Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia

Leukemia

Volumn 27, Issue 4, 2013, Pages 968-971

  Lane, A A ^a,b   Odejide, O ^a   Kopp, N ^a   Kim, S ^a   Yoda, A ^a   Erlich, R ^c,d   Wagle, N ^a,b   Abel, G A ^a,b   Rodig, S J ^a,b   Antin, J H ^a,b   Weinstock, D M ^a,b  

^a Department of Medical Oncology ^*  (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; APLASTIC ANEMIA; CD8+ T LYMPHOCYTE; CHILD; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GENE SEQUENCE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; ANEMIA, APLASTIC; ANTIGENS, CD; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MUTATION; YOUNG ADULT;

EID: 84876157061     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2013.30     Document Type: Letter

References (10)

1. Afable 2nd MG, Tiu RV, Maciejewski JP. Clonal evolution in aplastic anemia. Hematology Am Soc Hematol Educ Program 2011; 2011: 90-95.
2. Afable 2nd MG, Wlodarski M, Makishima H, Shaik M, Sekeres MA, Tiu RV et al. SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes. Blood 2011; 117: 6876-6884.
3. Katagiri T, Sato-Otsubo A, Kashiwase K, Morishima S, Sato Y, Mori Y et al. Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia. Blood 2011; 118: 6601-6609.
4. Wagle N, Berger MF, Davis MJ, Bluemensteil B, Defelice M, Pochanard P et al. Highthroughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing. Cancer Discov 2012; 2: 82-93.
5. Shih AH, Abdel-Wahab O, Patel JP, Levine RL. The role of mutations in epigenetic regulators in myeloid malignancies. Nat Rev Cancer 2012; 12: 599-612.
6. Zijlstra M, Bix M, Simister NE, Loring JM, Raulet DH, Jaenisch R. Beta 2-microglobulin deficient mice lack CD4-8\+ cytolytic T cells. Nature 1990; 344: 742-746.
7. Challa-Malladi M, Lieu YK, Califano O, Holmes AB, Bhagat G, Murty VV et al. Combined genetic inactivation of beta2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma. Cancer Cell 2011; 20: 728-740.
8. Welch JS, Ley TJ, Link DC, Miller CA, Larson DE, Koboldt DC et al. The origin and evolution of mutations in acute myeloid leukemia. Cell 2012; 150: 264-278.
9. Summers KE, Goff LK, Wilson AG, Gupta RK, Lister TA, Fitzgibbon J. Frequency of the Bcl-2/IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma. J Clin Oncol 2001; 19: 420-424.
10. Roulland S, Navarro JM, Grenot P, Milili M, Agopian J, Montpellier B et al. Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis. J Exp Med 2006; 203: 2425-2431.